Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Apr 2023 07:00 AM
RNS
Issue of share options to Non-Executive Directors
21 Apr 2023 07:00 AM
RNS
Issue of share options to Non-Executive Directors
18 Apr 2023 07:00 AM
RNS
ModiFY Phase 1/2 poster presentation at AACR 2023
17 Apr 2023 07:00 AM
RNS
Block Listing Application to AIM
13 Mar 2023 07:00 AM
RNS
Statement re: Silicon Valley Bank (SVB)
21 Feb 2023 09:05 AM
RNS
Second Price Monitoring Extn
21 Feb 2023 09:00 AM
RNS
Price Monitoring Extension
21 Feb 2023 07:00 AM
RNS
Encouraging early efficacy data from ModiFY trial
13 Feb 2023 07:00 AM
RNS
Positive response in COVIDITY trial
08 Feb 2023 07:00 AM
RNS
Issue of Equity
01 Feb 2023 07:00 AM
RNS
Dr Jean-Michel Cosséry appointed as Chairman
25 Jan 2023 07:00 AM
RNS
Interim Results
18 Jan 2023 07:00 AM
RNS
Notice of Interim Results
06 Dec 2022 04:40 PM
RNS
Second Price Monitoring Extn
06 Dec 2022 04:35 PM
RNS
Price Monitoring Extension
21 Nov 2022 03:18 PM
RNS
Result of Annual General Meeting
07 Nov 2022 07:00 AM
RNS
Licenses Vaccitech technology to advance Modi-2
31 Oct 2022 07:00 AM
RNS
First patient dosed in expansion phase of ModiFY
28 Oct 2022 03:00 PM
RNS
Notice of AGM
28 Oct 2022 07:00 AM
RNS
Results for the year ended 30 April 2022
26 Oct 2022 07:00 AM
RNS
Directorate Changes
25 Oct 2022 04:42 PM
RNS
Second Price Monitoring Extn
25 Oct 2022 04:37 PM
RNS
Price Monitoring Extension
25 Oct 2022 02:05 PM
RNS
Second Price Monitoring Extn
25 Oct 2022 02:00 PM
RNS
Price Monitoring Extension
25 Oct 2022 11:05 AM
RNS
Second Price Monitoring Extn
25 Oct 2022 11:00 AM
RNS
Price Monitoring Extension
25 Oct 2022 07:00 AM
RNS
Signs Commercial License Agreement with Genmab
13 Oct 2022 07:00 AM
RNS
Change of Nominated Adviser
28 Sep 2022 12:31 PM
RNS
Holding(s) in Company
23 Sep 2022 07:00 AM
RNS
Preclinical data at the EuroMAbNet Annual Meeting
06 Sep 2022 12:54 PM
RNS
Change of Registered Office
16 Aug 2022 02:00 PM
RNS
First patient dosed in Cohort 2 of the ModiFY
23 Jun 2022 07:00 AM
RNS
Scancell to produce TCB antibodies
15 Jun 2022 02:06 PM
RNS
Second Price Monitoring Extn
15 Jun 2022 02:00 PM
RNS
Price Monitoring Extension
15 Jun 2022 07:00 AM
RNS
Phase 2 SCOPE trial of SCIB1 vaccine expanded
13 Jun 2022 07:00 AM
RNS
First patient dosed in Modi-1 Phase 1 trial
12 Apr 2022 03:47 PM
RNS
Change of Registered Holder of Shares
11 Apr 2022 02:06 PM
RNS
Second Price Monitoring Extn
11 Apr 2022 02:00 PM
RNS
Price Monitoring Extension
11 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
11 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
11 Apr 2022 07:00 AM
RNS
Modi-1 Phase 1/2 trial open for recruitment
29 Mar 2022 07:00 AM
RNS
Update on COVIDITY clinical trial
17 Mar 2022 07:00 AM
RNS
Scancell progresses its new anti-glycan mAb
03 Mar 2022 09:55 AM
RNS
Director Dealing
31 Jan 2022 07:00 AM
RNS
Update on COVIDITY Phase 1 clinical trial
26 Jan 2022 07:00 AM
RNS
Interim Results for the 6 months ended 31 Oct 2021
22 Dec 2021 09:45 AM
RNS
Notice of Interim Results
UK 100